Exploring the Abundance of Biomarkers in Lung Cancer: Current Applications and Future Prospects for Precision Medicine

Get up to date on the latest clinical data guiding optimal use of biomarkers in the care of your patients with advanced NSCLC with this educational program featuring an interactive on-demand webcast and downloadable slidesets from a live CCO webinar.

Share

Program Content

No activities added yet

Activities

Molecular Testing/Immunotherapy
Molecular Testing Overview and Biomarkers Predicting Response to Immune-Based Therapies in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2021

Expires: June 27, 2022

<i>EGFR</i>, <i>EGFR</i> ex20ins, <i>HER2</i>
Predictive Biomarkers for Targeted Therapies in Advanced NSCLC: EGFR mutations, EGFR Exon 20 Insertions, and HER2 Mutations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2021

Expires: June 27, 2022

<i>ALK, ROS1, RET, NTRK, KRAS</i> G12C, <i>MET</i>ex14
Predictive Biomarkers for Targeted Therapies in Advanced NSCLC: ALK and ROS1 Rearrangements, RET and NTRK Fusions, and KRAS G12C and METex14 Mutations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2021

Expires: June 27, 2022

<i>EP</i>: NSCLC Biomarkers 2021
ExpressPoints
Exploring the Abundance of Biomarkers in Lung Cancer: Current Applications and Future Prospects for Precision Medicine
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2021

Expires: July 07, 2022

Faculty

cover img faculity

Stephen Liu, MD

Assistant Professor of Medicine
Department of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

cover img faculity

Suresh S. Ramalingam, MD

Associate Professor
Director,
Division of Medical Oncology
Emory University, Winship Cancer Institute
Atlanta, Georgia

cover img faculity

Lecia V. Sequist, MD, MPH

The Landry Family Professor of Medicine
Harvard Medical School
Director, Center for Innovation in Early Cancer Detection
Massachusetts General Hospital
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Turning Point Therapeutics Inc